美股新聞 標題聯播 · 近 24 小時 283 則 · 25 個來源 · 最新 9/20 07:00
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · ORGO近 30 天 0 則 · 第 1 / 1 頁
- Organogenesis (ORGO) Q2 2026 Earnings Call Transcript
- Organogenesis Holdings (ORGO) Stock Fair Value Moves Lower After Guidance Cut And Analyst Caution
- Organogenesis Holdings (ORGO) Is Down 21.5% After Slashing 2026 Guidance And Launching Equity Offering – Has The Bull Case Changed?
- Organogenesis Holdings Inc. Q2 2026 Earnings Call Summary
- Organogenesis Q2 Earnings Call Highlights
- Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results
- Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers
- Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
- Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis
- Is Organogenesis Holdings Inc. (ORGO) Losing Momentum? BTIG Pulls Buy Rating After Q1 Update
- Spotlight On Penny Stocks To Consider In May 2026
- Undervalued Small Caps With Insider Buying To Watch In May 2026
- Organogenesis (ORGO) Q1 2026 Earnings Transcript
- Organogenesis Holdings Inc. Q1 2026 Earnings Call Summary
- Organogenesis Q1 Earnings Call Highlights
- Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results
- Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
- Undiscovered Gems In The US Market Featuring 3 Promising Stocks
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。